コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 n, perform a test, and interpret the results privately.
2 ng to assess reputations, either publicly or privately.
4 ound that adolescents behaved selfishly when privately allocating monetary rewards for themselves and
6 olled experiment allowing individuals to lie privately and anonymously to benefit themselves and fell
7 oods contributions when people are solicited privately and impersonally (e.g., mail, email, social me
9 declared that data or code were publicly or privately available (declared availability) and the succ
10 We show that, in a structured population, privately computed optimal behavioral responses may lead
16 ucation, size of school, and publicly versus privately funded school did not alter the association.
19 rdiomyopathy centers had access to different privately held data when making their classifications (7
21 sychological and navigational integration of privately hosted refugees, with no discernible effects o
24 perforation rate fell in the middle between privately insured (24.1%) and publicly insured or nonins
27 74.2 [14.1]), male (68.3% versus 61.4%), and privately insured (45.9% versus 28.9%) individuals (P<0.
29 Caucasian (85.7%), 18-39 years old (52.2%), privately insured (81.5%), and at academic centers (73.7
30 24 adults [5.5%] to 200/3593 adults [7.0%]), privately insured (881/14 387 adults [6.1%] to 1154/13 4
33 9%], 22 707 male adolescents [56.1%], 11 392 privately insured [62.6%], and 32 674 above the poverty
34 .6 [6.2] years; 355 nulliparous [54.9%]; 558 privately insured [86.2%]), 414 (64.0%) received the RSV
35 1.15 [95% CI, 1.13-1.17]; P<0.001) and less privately insured admissions (adjusted odds ratio, 0.85
36 om January 1 to December 31, 2012, of 13,103 privately insured adolescents aged 13 to 21 years (mean
37 e is known about health care expenditures of privately insured adolescents, especially those who incu
39 CIPANTS: This cross-sectional study included privately insured adults and adult Medicare beneficiarie
40 nterval (CI) -27.9% to -3.2%), but not among privately insured adults in control states ($2704 to $25
41 ut-of-pocket spending showed a decline among privately insured adults in intervention states (from $3
42 was observed in out-of-pocket spending among privately insured adults in intervention states compared
44 out-of-pocket spending among direct purchase privately insured adults who gained NSA surprise billing
45 deidentified administrative claims data for privately insured adults with diabetes from a single ins
46 mated to be approximately $156.2 billion for privately insured adults younger than 65 years in the US
47 r types was approximately $156.2 billion for privately insured adults younger than 65 years in the US
51 nts, regarding COVID-19 hospitalizations for privately insured and Medicare Advantage patients from M
53 ly to be sociodemographically advantaged and privately insured and to live in regions with reduced ac
54 ed as-treated aHR, 1.01 [95% CI, 0.79-1.29]; privately insured as-treated aHR, 0.87 [95% CI, 0.44-1.7
55 ed as-treated aHR, 1.44 [95% CI, 1.25-1.65]; privately insured as-treated aHR, 1.21 [95% CI, 0.93-1.5
59 We performed a retrospective cohort study of privately insured beneficiaries who had an emergency dep
60 enied an appointment as compared with 11% of privately insured callers (29 of 273) (relative risk, 6.
62 e 30 years and older; 57.9% of mothers had a privately insured child, 35.7% had a publicly insured ch
63 ldren (1 045 426 boys [50.5%]) and 1 309 900 privately insured children (667 607 boys [51.0%]) enroll
64 P enrollees was 22 days longer than that for privately insured children (95% CI, 6.8 to 37.5; P=0.005
65 IP, 77% [76%-79%]; P < .01) visits than were privately insured children (medical, 83% [82%-84%]; dent
66 in tests, including 12 834 (21.7%) of 59 178 privately insured children and 23 198 (23.8%) of 97 595
67 creening, including 13 939 (23.6%) of 59 178 privately insured children and 28 910 (29.6%) of 97 595
68 h services, including pharmacotherapy, among privately insured children and adolescents from 1997 to
69 orable comparisons between the experience of privately insured children and that of publicly insured
70 ange in insulin out-of-pocket spending among privately insured children and young adults with type 1
71 Race and ethnicity were not available for privately insured children because these data are not re
75 9% of publicly insured children and 11.0% of privately insured children received a diagnosis of 1 or
78 These challenges were also magnified for privately insured children with special health care need
79 cly insured children and 15.0% vs 6.7% among privately insured children) and White children (30.2% vs
83 n with Medicaid relative to a control group, privately insured counterparts, served to separate Medic
85 years after donation in the Medicare- versus privately insured donors included the following: maligna
86 efits, and health productivity for 3 million privately insured employees, their dependents, and early
89 staff posed as either Medicaid enrollees or privately insured enrollees seeking new-patient primary
90 ssion, or adjustment disorder (N=19,094) and privately insured enrollees unaffected by the policy in
91 A retrospective cross-sectional analysis of privately insured female patients undergoing immediate b
93 non-HMGs (OR: 1.16; 95% CI: 1.03-1.31), but privately insured HMG and non-HMG did not differ signifi
94 f-pocket spending exceeded $4000 for 2.5% of privately insured hospitalizations compared with 0.2% of
96 to 0.33%], and -0.57% [-2.08% to 0.74%]) and privately insured individuals (estimated difference, -0.
98 deidentified administrative claims data for privately insured individuals and Medicare Advantage ben
99 ms data from the OptumLabs Data Warehouse of privately insured individuals and Medicare Advantage enr
101 ortality among Medicaid beneficiaries versus privately insured individuals hospitalized with ST-segme
102 nsurance claims database includes 14 million privately insured individuals in 69 self-insured compani
104 ) from a national study group of 3.9 million privately insured individuals per year from 1993 to 1995
105 a national database of insurance claims for privately insured individuals under age 65, locating inp
106 a national database of more than 1.7 million privately insured individuals were used in an analysis o
107 source of income (serving general public vs privately insured individuals) and ICU size (ten or fewe
108 ECT was greater for older patients, whites, privately insured individuals, and patients who lived in
109 ndar year 2018 from a sample of 27.1 million privately insured individuals, including patients with a
118 uroimaging (62.0%; 95% CI, 60.0%-64.1%) than privately insured infants (55.1%; 95% CI, 51.8%-58.4%) (
121 cost and use of targeted therapeutics among privately insured nonelderly patients with cancer receiv
122 1992 through 2004 among 5158 adults who were privately insured or uninsured before Medicare coverage
123 e white, employed, cohabiting or married, or privately insured or who had prior intolerance to citalo
126 ces was reported for 63 hospitalizations for privately insured patients (4.6%) and 36 hospitalization
127 eported for 981 of 1377 hospitalizations for privately insured patients (71.2%) and 1324 of 2968 hosp
128 95% CI, 1.11-1.25), and publicly insured vs privately insured patients (aHR, 1.09; 95% CI, 1.03-1.15
130 re less likely to receive immunotherapy than privately insured patients (OR, 0.31; 95% CI, 0.20-0.48;
131 mercial Database (which contains claims from privately insured patients across the US) and the 2018-2
132 rt study used US commercial claims data from privately insured patients aged 0 to 17 years from Janua
133 This retrospective cohort analysis included privately insured patients aged 18 to 63 years from a la
135 out-of-pocket spending was $3840 ($3186) for privately insured patients and $1536 ($1402) for Medicar
136 out-of-pocket spending was $788 ($1411) for privately insured patients and $277 ($363) for Medicare
137 nal claims database representing 7.7 million privately insured patients and 1.0 million Medicare Adva
138 claims for 23 million and 14 million annual privately insured patients and Medicaid beneficiaries, r
139 hich contains medical and pharmacy claims on privately insured patients and Medicare Advantage enroll
140 pecially among clinicians primarily treating privately insured patients and those applying it premand
142 ificantly less likely to be transferred than privately insured patients for 4 diagnoses: biliary trac
144 esection for colorectal cancer compared with privately insured patients in both Massachusetts and the
145 infection episodes used a national sample of privately insured patients in outpatient care from the I
146 t difference was found between uninsured and privately insured patients in the adjusted odds of WLST
147 ntal opioid prescriptions among publicly and privately insured patients in the United States from 201
150 (estimated from MarketScan) by the number of privately insured patients living with that cancer in 20
152 MarketScan insurance claims data for 678220 privately insured patients receiving chemotherapy before
153 eceipt of guideline therapy, with 65% of the privately insured patients receiving recommended therapy
154 ment cards can lower out-of-pocket costs for privately insured patients taking brand-name prescriptio
155 D involvement leads to better outcomes among privately insured patients under age 65 years hospitaliz
157 to characterize how UCCs manage Medicaid and privately insured patients who present with an emergent
159 tratifying analyses by insurance status, non-privately insured patients who resided in areas with low
160 c mental hospitals in a prior period replace privately insured patients who, under managed care, are
164 Retrospective cohort study among 831 471 privately insured patients with first stroke in the USA
166 ation was most evident for younger patients, privately insured patients, and patients who were not pr
167 d lipid-lowering therapy, respectively, than privately insured patients, and patients with public ins
168 flects potential overuse in whites, men, and privately insured patients, in addition to underuse in d
170 erage was reduced to 50% of that observed in privately insured patients, the strategy of extending dr
187 y to present with advanced-stage cancer than privately insured patients; however, this finding has no
188 AND PARTICIPANTS: This cohort study included privately insured people 10 to 29 years of age identifie
190 correlated with variations in the ability of privately insured persons to obtain care (Pearson r, 0.0
191 nt care of acute-phase major depression in a privately insured population as well as the effectivenes
192 erences between these findings and those for privately insured populations highlight the pitfalls of
193 TS: In this cross-sectional study of 460 371 privately insured postpartum women who delivered a singl
194 a was separated into cohorts of publicly and privately insured pregnant individuals and their childre
196 drug coverage was estimated from a cohort of privately insured transplant recipients who receive life
199 escribing also significantly increased among privately insured visits and visits in which neither ant
200 as did publicly insured youths compared with privately insured youths (estimated difference, 0.39% [9
202 At-risk API patients in Cohort 1 (primarily privately insured) and Cohort 2 (includes Medicare and/o
203 for uninsured patients (reference category, privately insured) while patient- and hospital-level fac
204 rs), 48% (n = 3631) Medicare, 48% (n = 3667) privately insured, and 4% (n = 331) Medicaid patients.
205 usion criteria, 57.1% were white, 48.8% were privately insured, and most were 45 years and older (51.
206 ) were less likely to receive LVADs than the privately insured, and patients in low-income ZIP codes
208 ceive NOM than were patients who were white, privately insured, and treated at a high-volume facility
209 S.(1) Using this data, we identified 518,195 privately insured, cancer-free, and opioid-naive (no fil
210 rgery alone were more likely to: be younger, privately insured, have no comorbidities, pT3 disease, p
214 sured and Medicaid-insured compared with the privately insured, women compared with men, and other ri
223 ale) and 211 460 in the MarketScan database (privately insured; mean [SD] age, 15.8 [2.3] years; 63.9
224 recipient (OR, 1.12 [CI, 1.10-1.15]) versus privately insured; or in the Midwest (OR, 1.32 [CI, 1.28
225 nvestigators posed as either a Medicaid or a privately-insured patient with symptoms of an incarcerat
229 volume of births and confounders (public or privately managed, availability of antiretroviral therap
230 or a nationwide sample of publicly (MAX) and privately (MarketScan) insured mother-child dyads with u
231 nitoba between September 2006 and April 2010 privately (n = 3,541) were matched on age to up to three
236 tbreak and control measures implemented at a privately operated detention facility housing US Immigra
237 QR, 3.5-5]) websites were more accurate than privately owned (median accuracy score, 3.5 [IQR, 1.5-4]
239 ded, because measuring indoor air quality in privately owned buildings is often logistically and fina
241 battery electric vehicles and switching from privately owned cars to carsharing substantially impacts
242 he current mobility system relies heavily on privately owned cars, which results in high levels of em
246 eye clinics at a large government-owned or a privately owned health facility in Enugu, Nigeria, betwe
249 ignificant sample of Iranian gasoline-fueled privately owned light duty vehicles (LDVs) operated in T
253 Q), was used, and breed group differences of privately-owned dogs from Japan (n = 2,951) and the Unit
254 ctices, and 15% (primarily academic) were in privately-owned practices in which all physicians were e
255 ted the tenets of Darwinian evolution, while privately pinpointing aspects of Darwin's views of inher
256 Our results demonstrate the potential for privately profitable, as well as publicly beneficial, im
258 ffective area-based conservation measures or privately protected areas, could deliver conservation ou
263 not associated with changes in the number of privately sponsored health insurance advertisements aire
265 inicalTrials.gov, a registry of publicly and privately supported clinical studies, on February 20, 20
266 -use OTC syphilis test allows individuals to privately test at home and can promote testing among tho
267 o 3.5 percentage points) than lower incomes, privately than publicly (difference, -2.5 percentage poi
268 hich can affect other cells, repression acts privately: the de-repression of QS in comQ cells is intr
269 tanford University Hospital was administered privately to each eligible patient of 2 different attend
270 the absence of quality surveillance data on privately treated patients, commercial drug sales data o
273 sers may choose to: (1) view their data sets privately without sharing; (2) share with other register